Ankyra Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing "anchored" immunotherapies for cancer and immune-mediated diseases. Its proprietary platform tethers immune-modulating drugs to aluminum hydroxide so that treatment concentrates locally at the disease site, broadening the therapeutic window… - View it on GitHub